MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/117.5/0.1/20.12.24 Share Price

Warrant

DE000MG4D310

Real-time Bid/Ask 05:42:07 26/06/2024 pm IST
0.1 EUR / 0.133 EUR +6.36% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/117.5/0.1/20.12.24
Current month-75.56%
1 month-88.30%
Date Price Change
26/24/26 0.099 -10.00%
25/24/25 0.11 -24.14%
24/24/24 0.145 -8.81%
21/24/21 0.159 -0.63%
20/24/20 0.16 -13.51%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 05:28 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4D31
ISINDE000MG4D310
Date issued 16/05/2024
Strike 117.5 $
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 1.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.04
Lowest since issue 0.099
Spread 0.023
Spread %18.85%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
55.86 USD
Average target price
83.43 USD
Spread / Average Target
+49.36%
Consensus